Literature DB >> 744579

Somatostatin analogs as glucagon suppressants in diabetes.

V Schusdziarra, J Rivier, R Dobbs, M Brown, W Vale, R Unger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 744579     DOI： 10.1055/s-0028-1095849

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN： 0018-5043            Impact factor:   2.936


× No keyword cloud information.
  5 in total

1.  Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats.

Authors:  C L Brand; B Rolin; P N Jørgensen; I Svendsen; J S Kristensen; J J Holst
Journal:  Diabetologia       Date:  1994-10       Impact factor: 10.122

2.  Effect of the somatostatin analog D-Trp8,D-Cys14 on glucose insulin, pancreatic glucagon and growth hormone plasma levels in acromegalics and mild diabetics.

Authors:  M Trovati; F Massara; F Camanni; G M Molinatti; R Lorenzati; G F Pagano
Journal:  J Endocrinol Invest       Date:  1980 Apr-Jun       Impact factor: 4.256

3.  Effect of a somatostatin analog on insulin requirement and hormone levels in 6 insulin-dependent juvenile-onset diabetics subjected to artificial pancreas.

Authors:  G Lenti; M Trovati; R Lorenzati; F Vitelli; V Tagliaferro; A Marocco; G Pagano
Journal:  Acta Diabetol Lat       Date:  1980 Jan-Mar

4.  Effects of calcium and calcitonin on circulating levels of glucagon and glucose in diabetes mellitus.

Authors:  A Starke; E Keck; M Berger; H Zimmermann
Journal:  Diabetologia       Date:  1981-05       Impact factor: 10.122

5.  Bypassed and Preserved Stomach Resulted in Superior Glucose Control in Sprague-Dawley Rats with Streptozotocin-Induced Diabetes.

Authors:  Jason Widjaja; Ponnie Robertlee Dolo; Qiang Zhang; Libin Yao; Chao Li; Jian Hong; Hui Wang; Song Meng; Yong Shao; Xiaocheng Zhu
Journal:  Sci Rep       Date:  2019-07-10       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.